Evidence check: CYP2D6 in the context of fertility

CYP2D6 is primarily a drug-metabolizing enzyme, not directly linked to fertility. Some studies suggest possible associations between CYP2D6 polymorphisms and hormone levels (e.g., estrogen) or response to fertility treatments, but the evidence is weak and inconsistent. Most data come from pharmacogenetic research on tamoxifen or antidepressants, not from dedicated fertility studies. Direct-to-consumer tests often overstate the clinical significance of single variants. A proven effect on natural fertility is lacking. Therefore, interpretation should be cautious; medical consultation is advised, especially if taking medications metabolized by CYP2D6.